Phase 1b trial of BXQ 350.
Phase of Trial: Phase I
Latest Information Update: 19 Sep 2017
At a glance
- Drugs Saposin C (Primary)
- Indications Glioma; Solid tumours
- Focus Adverse reactions
- 19 Sep 2017 New trial record
- 06 Sep 2017 According to a Bexion Pharmaceuticals media release, the highest dose tested in phase 1a trial will be used in this trial.